Innoprot will be present in the AD/PD 2017, the 13th International Conference on Alzheimer’s / Parkinson’s Diseases, which will take place in Viena, Austria from 29th, March to 2nd, April, 2017.
AD/PDTM 2017, the 13th International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders, will build on the well-earned reputation of previous AD/PDTM Conferences for unraveling the mechanisms and improving the treatment of Alzheimer’s, Parkinson’s and other related neurodegenerative diseases.
You can visit us in the stand No 45 and ask us regaring our products and our CNS Screening Platform.
Metabolic syndrome is characterized by dysregulated glucose metabolism and is
We are pleased to announce that Innoprot has been recognised
Acetyl-l-carnitine (ALC) is synthesized in the brain, liver, and kidneys
Neural stem cell (NSC) proliferation and differentiation in the mammalian
Allergic conjunctivitis (AC) is the most common form of allergic
The hepatic content of amyloid beta (Aβ) decreases drastically in